Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Author signatures for legal purposes
Closed-loop adaptive adjustment of pacing therapy based on cardiogenic impedance signals detected by an implantable medical device
Machine tool with an electrical generator for passive power generation
Systems and methods for providing a video playlist
Multilevel directory assistance apparatus and method
Collaborative computing community role mapping system and method
Motilin-like peptide compound having transmucosal absorbability imparted thereto
  Randomly Featured Patents
Embroidering machine having first-order mass compensation
Ultrasonic transducers for wire bonding and methods of forming wire bonds using ultrasonic transducers
Wafer carrying device and wafer carrying method
.beta.-form tris-(2, 3-epoxypropyl)-isocyanurate crystals and process for their production
Apparatus for stripping hides from animals
Autonomous guided vehicle guidance device
Egg beater
Vertical holder for paper inserts
Table frame
Process for preparation of solid tris (2,3-dibromopropyl) isocyanurate